US-Australian drug discovery company, Novogen Ltd, (NASDAQ: NVGN), its subsidiary, CanTx, Inc, and Yale University today disclosed key pre-clinical data ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE